Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease
Clinical trial NCT00035880 · COMPLETED
Trial details
- NCT number
- NCT00035880
- Sponsor
- Abgenix
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-10-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.